Nepean Hospital
Kingswood, NSW 2751
0 studies enrolling now · 3 studies all time
What they study most
B-Cell Chronic Lymphocytic Leukemia, B-cell Chronic Lymphocytic Leukemia, Crohn Disease
Studies at this site
- A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy — Completed
- Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
- Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial) — Completed